Jennison Associates’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-257,939
| Closed | -$37.8M | – | 726 |
|
|
2021
Q4 | $37.8M | Sell |
257,939
-4,382
| -2% | -$643K | 0.02% | 269 |
|
|
2021
Q3 | $46.4M | Buy |
262,321
+89,329
| +52% | +$15.8M | 0.03% | 232 |
|
|
2021
Q2 | $27.9M | Buy |
172,992
+89,395
| +107% | +$14.4M | 0.02% | 324 |
|
|
2021
Q1 | $14.3M | Buy |
+83,597
| New | +$14.3M | 0.01% | 389 |
|
|
2020
Q3 | – | Sell |
-504,451
| Closed | -$57.6M | – | 699 |
|
|
2020
Q2 | $57.6M | Sell |
504,451
-78,468
| -13% | -$8.96M | 0.05% | 147 |
|
|
2020
Q1 | $44.8M | Sell |
582,919
-4,768
| -0.8% | -$367K | 0.05% | 156 |
|
|
2019
Q4 | $75.7M | Sell |
587,687
-132,714
| -18% | -$17.1M | 0.08% | 142 |
|
|
2019
Q3 | $56.1M | Sell |
720,401
-246,930
| -26% | -$19.2M | 0.06% | 179 |
|
|
2019
Q2 | $99.6M | Sell |
967,331
-225,348
| -19% | -$23.2M | 0.1% | 118 |
|
|
2019
Q1 | $87.4M | Sell |
1,192,679
-23,785
| -2% | -$1.74M | 0.09% | 133 |
|
|
2018
Q4 | $51.6M | Buy |
1,216,464
+217,960
| +22% | +$9.25M | 0.06% | 202 |
|
|
2018
Q3 | $47M | Buy |
998,504
+383,785
| +62% | +$18.1M | 0.04% | 261 |
|
|
2018
Q2 | $30.3M | Buy |
614,719
+86,323
| +16% | +$4.26M | 0.03% | 341 |
|
|
2018
Q1 | $16.2M | Buy |
528,396
+40,797
| +8% | +$1.25M | 0.02% | 415 |
|
|
2017
Q4 | $8.9M | Buy |
+487,599
| New | +$8.9M | 0.01% | 469 |
|
|
2016
Q2 | – | Sell |
-65,789
| Closed | -$1.41M | – | 656 |
|
|
2016
Q1 | $1.41M | Buy |
65,789
+535
| +0.8% | +$11.5K | ﹤0.01% | 539 |
|
|
2015
Q4 | $2.06M | Buy |
65,254
+254
| +0.4% | +$8.03K | ﹤0.01% | 549 |
|
|
2015
Q3 | $2.24M | Buy |
+65,000
| New | +$2.24M | ﹤0.01% | 579 |
|